J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

Data Compilation
#PharmaFlow

Pipeline Prospector May 2025: Pfizer strikes US$ 6 bn oncology pact; Lilly diversifies pipeline with US$ 2.3 bn in deals

Stock Recap
#PipelineProspector

Polaramin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

15 API Suppliers, 6 USDMF, 1 CEP/COS, 3 EU WC, 3 KDMF, 3 NDC API, 8 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

22 FDF Dossiers, 14 FDA Orange Book, 2 Europe, 3 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION, EXTENDED RELEASE;ORAL - EQ 2.8MG BASE/5ML;EQ 14.7MG BASE/5ML, SYRUP;ORAL - 2MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Rochem International Inc, 3 SPI Pharma, 4 DKSH, 2 Pharm-RX Chemical, 3 Faran Shimi Pharmaceutical, 7 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 6 Actylis, 1 Alcedo Pharmachem, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 7 BASF, 1 Bioplus Life Sciences, 4 DFE Pharma, 1 Finar, 7 Gangwal Chemicals, 1 Ideal Cures, 19 Kerry, 10 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 4 Pluviaendo, 2 Prachin Chemical, 18 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 8 Sigachi Industries, 2 Silverline Chemicals, 2 Ulanqab Kema New Material, 1 Valens Pharmachem, 2 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 18 Direct Compression, 18 Thickeners and Stabilizers, 16 Co-Processed Excipients, 16 Disintegrants & Superdisintegrants, 14 Film Formers & Plasticizers, 13 Granulation, 12 Taste Masking, 11 Lubricants & Glidants, 10 Coating Systems & Additives, 9 Parenteral, 7 Topical, 7 Chewable & Orodispersible Aids, 6 Solubilizers, 6 Controlled & Modified Release, 4 Emulsifying Agents, 3 Rheology Modifiers, 3 API Stability Enhancers, 1 Soft Gelatin

DIGITAL CONTENT

4 News #PharmaBuzz

4 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 Regulatory FDF Prices

2 Regulatory FDF Prices

MARKET PLACE

7 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 US Patents

2 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 1 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
28/06/2025	Supriya Lifescience	India	IMCD Korea Co., Ltd.	20210302-211-J-852(2)	Dexchlorpheniramine maleate	2024-09-11	Supriya Lifescience Ltd.	India	A-5/2, Lote Parshuram Industrial Area, MIDC Tal-Khed. Dist-Ratnagiri, Maharashtra, Pin-415 722, India
28/06/2025	Supriya Lifescience	India	Daeshin Pharmaceutical Co., Ltd.	20210302-211-J-852(1)	Dexchlorpheniramine maleate	2021-12-06	Supriya Lifescience Ltd.	India	A-5/2, Lote Parshuram Industrial Area, MIDC Tal-Khed. Dist-Ratnagiri, Maharashtra, Pin-415 722, India

Polaramin

Polaramin

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

15 API Suppliers

6 USDMF

1 CEP/COS

3 EU WC

3 KDMF

3 NDC API

8 Listed Suppliers

$ API Reference Price

FINISHED DOSAGE FORMULATIONS

22 FDF Dossiers

14 FDA Orange Book

2 Europe

3 South Africa

3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 2.8MG BASE/5ML;EQ 14.7MG BASE/5ML

SYRUP;ORAL - 2MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

4 Rochem International Inc

3 SPI Pharma

4 DKSH

2 Pharm-RX Chemical

3 Faran Shimi Pharmaceutical

7 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Pfanstiehl

6 Actylis

1 Alcedo Pharmachem

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Ashland

7 BASF

1 Bioplus Life Sciences

4 DFE Pharma

1 Finar

7 Gangwal Chemicals

1 Ideal Cures

19 Kerry

10 Microlex e.U

2 Nitika Pharmaceutical Specialities

1 Novo Excipients

2 Pharmatrans-Sanaq

4 Pluviaendo

2 Prachin Chemical

18 Roquette

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

1 Shanghai Welltone Material Technology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

8 Sigachi Industries

2 Silverline Chemicals

2 Ulanqab Kema New Material

1 Valens Pharmachem

2 Vasa Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders

18 Direct Compression

18 Thickeners and Stabilizers

16 Co-Processed Excipients

16 Disintegrants & Superdisintegrants

14 Film Formers & Plasticizers

13 Granulation

12 Taste Masking

11 Lubricants & Glidants

10 Coating Systems & Additives

9 Parenteral

7 Topical

7 Chewable & Orodispersible Aids

6 Solubilizers

6 Controlled & Modified Release

4 Emulsifying Agents

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons